{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:54:10Z","timestamp":1790283250355,"version":"4.1.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cryptococcus gattii represents an emerging fungal pathogen of immunocompromised and immunocompetent hosts in the United States. To our knowledge, this is the first case of posttransplant immune reconstitution syndrome due to C. gattii meningoencephalitis successfully treated with corticosteroids. We also report successful maintenance phase treatment with isavuconazole, a novel triazole, following fluconazole-induced prolonged QT syndrome.<\/jats:p>","DOI":"10.1093\/ofid\/ofz460","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T18:26:10Z","timestamp":1571855170000},"source":"Crossref","is-referenced-by-count":8,"title":["Corticosteroids for Posttransplant Immune Reconstitution Syndrome in Cryptococcus gattii Meningoencephalitis: Case Report and Literature Review"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3671-311X","authenticated-orcid":false,"given":"Gregory S","family":"Canfield","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s F","family":"Henao-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8757-643X","authenticated-orcid":false,"given":"Carlos","family":"Franco-Paredes","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA"},{"name":"Hospital Infantil de Mexico, Federico Gomez, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Zhelnin","sequence":"additional","affiliation":[{"name":"Deparment of Pathology, Denver Health Medical Center, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-0100","authenticated-orcid":false,"given":"Michael L","family":"Wilson","sequence":"additional","affiliation":[{"name":"Deparment of Pathology, Denver Health Medical Center, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine C","family":"Shihadeh","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Denver Health Medical Center, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wyles","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Denver Health Medical Center, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-1141","authenticated-orcid":false,"given":"Edward M","family":"Gardner","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Denver Health Medical Center, Denver, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,23]]},"reference":[{"key":"2020012206163469300_CIT0001","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/AAC.04055-14","article-title":"Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for the Cryptococcus neoformans-Cryptococcus gattii species complex using the CLSI M27-A3 broth microdilution method","volume":"59","author":"Espinel-Ingroff","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2020012206163469300_CIT0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diagmicrobio.2012.02.018","article-title":"Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility","volume":"73","author":"Lockhart","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020012206163469300_CIT0004","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/cid\/civ571","article-title":"Isavuconazole: a new broad-spectrum triazole antifungal agent","volume":"61","author":"Miceli","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0005","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/cid\/cir723","article-title":"Cryptococcus gattii in the United States: clinical aspects of infection with an emerging pathogen","volume":"53","author":"Harris","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0006","doi-asserted-by":"crossref","first-page":"e00912","DOI":"10.1128\/mBio.00912-14","article-title":"Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients","volume":"5","author":"Saijo","year":"2014","journal-title":"MBio"},{"key":"2020012206163469300_CIT0007","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S1473-3099(14)70945-4","article-title":"Management of Cryptococcus gattii meningoencephalitis","volume":"15","author":"Franco-Paredes","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2020012206163469300_CIT0008","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3201\/eid2411.180787","article-title":"Cryptococcus gattii complex infections in HIV-infected patients, Southeastern United States","volume":"24","author":"Bruner","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"2020012206163469300_CIT0009","first-page":"865","article-title":"Emergence of Cryptococcus gattii-- Pacific Northwest, 2004\u20132010","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020012206163469300_CIT0010","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/mSphere.00241-17","article-title":"Furthering the continental drift speciation hypothesis in the pathogenic cryptococcus species complexes","volume":"2","author":"Engelthaler","year":"2017","journal-title":"mSphere"},{"key":"2020012206163469300_CIT0011","first-page":"675213","article-title":"Global molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii: an atlas of the molecular types","volume":"2013","author":"Cogliati","year":"2013","journal-title":"Scientifica (Cairo)"},{"key":"2020012206163469300_CIT0012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/tid.12370","article-title":"Cryptococcus gattii infection in solid organ transplant recipients: description of Oregon outbreak cases","volume":"17","author":"Forrest","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"2020012206163469300_CIT0013","first-page":"525","article-title":"A multicenter, longitudinal cohort study of Cryptococcosis in HIV-negative people in the United States","volume":"23","author":"Marr","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0014","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.043","article-title":"Lacunar stroke in cryptococcal meningitis: clinical and radiographic features","volume":"28","author":"Vela-Duarte","year":"2019","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2020012206163469300_CIT0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/cid\/cir276","article-title":"Opportunistic infection-associated immune reconstitution syndrome in transplant recipients","volume":"53","author":"Sun","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/cid\/ciu711","article-title":"Predictors of immune reconstitution syndrome in organ transplant recipients with cryptococcosis: implications for the management of immunosuppression","volume":"60","author":"Sun","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0017","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1046\/j.1365-2958.2001.02295.x","article-title":"Calcineurin regulatory subunit is essential for virulence and mediates interactions with FKBP12-FK506 in Cryptococcus neoformans","volume":"39","author":"Fox","year":"2001","journal-title":"Mol Microbiol"},{"key":"2020012206163469300_CIT0018","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1093\/emboj\/19.14.3618","article-title":"Identification and characterization of a highly conserved calcineurin binding protein, CBP1\/calcipressin, in Cryptococcus neoformans","volume":"19","author":"G\u00f6rlach","year":"2000","journal-title":"EMBO J"},{"key":"2020012206163469300_CIT0019","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cit341","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"57","author":"Chen","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/603554","article-title":"Dexamethasone in Cryptococcus gattii central nervous system infection","volume":"49","author":"Phillips","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0021","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1086\/424746","article-title":"Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman","volume":"39","author":"Einsiedel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0022","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1212\/01.WNL.0000134677.29120.62","article-title":"Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis","volume":"63","author":"Lane","year":"2004","journal-title":"Neurology"},{"key":"2020012206163469300_CIT0023","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mycmed.2016.09.003","article-title":"Corticosteroids for the management of severe intracranial hypertension in meningoencephalitis caused by Cryptococcus gattii: a case report and review","volume":"27","author":"Maciel","year":"2017","journal-title":"J Mycol Med"},{"key":"2020012206163469300_CIT0024","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0035-9203(97)90393-X","article-title":"The effect of corticosteroids on visual loss in Cryptococcus neoformans var. gattii meningitis","volume":"91","author":"Seaton","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2020012206163469300_CIT0025","doi-asserted-by":"crossref","first-page":"e1004884","DOI":"10.1371\/journal.ppat.1004884","article-title":"Paradoxical immune responses in non-HIV Cryptococcal meningitis","volume":"11","author":"Panackal","year":"2015","journal-title":"PLOS Pathog"},{"key":"2020012206163469300_CIT0026","doi-asserted-by":"crossref","first-page":"ofy007","DOI":"10.1093\/ofid\/ofy007","article-title":"Rapid reversal of complete binocular blindness with high-dose corticosteroids and lumbar drain in a solid organ transplant recipient with cryptococcal meningitis and immune reconstitution syndrome: first case study and literature review","volume":"5","author":"Weiss","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2020012206163469300_CIT0027","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1111\/j.1600-6143.2007.01994.x","article-title":"Cellulitis revealing a cryptococcosis-related immune reconstitution inflammatory syndrome in a renal allograft recipient","volume":"7","author":"Lanternier","year":"2007","journal-title":"Am J Transplant"},{"key":"2020012206163469300_CIT0028","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/lt.21601","article-title":"Immune reconstitution syndrome after voriconazole treatment for cryptococcal meningitis in a liver transplant recipient","volume":"14","author":"Crespo","year":"2008","journal-title":"Liver Transpl"},{"key":"2020012206163469300_CIT0029","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1399-3062.2010.00592.x","article-title":"Immune reconstitution inflammatory syndrome mimicking relapsing cryptococcal meningitis in a renal transplant recipient","volume":"13","author":"Legris","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"2020012206163469300_CIT0030","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJMoa1509024","article-title":"Adjunctive dexamethasone in HIV-associated cryptococcal meningitis","volume":"374","author":"Beardsley","year":"2016","journal-title":"N Engl J Med"},{"key":"2020012206163469300_CIT0031","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cid\/ciw305","article-title":"Isavuconazole treatment of cryptococcosis and dimorphic mycoses","volume":"63","author":"Thompson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2020012206163469300_CIT0032","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/AAC.01292-17","article-title":"Tissue distribution and elimination of isavuconazole following single and repeat oral-dose administration of isavuconazonium sulfate to rats","volume":"61","author":"Schmitt-Hoffmann","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2020012206163469300_CIT0033","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.00546-19","article-title":"Pharmacodynamics of isavuconazole in a rabbit model of cryptococcal meningoencephalitis","volume":"63","author":"Kovanda","year":"2019","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofz460\/30268526\/ofz460.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/11\/ofz460\/31910383\/ofz460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/6\/11\/ofz460\/31910383\/ofz460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T11:16:42Z","timestamp":1579691802000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofz460\/5603785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,23]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofz460","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,10,23]]},"article-number":"ofz460"}}